Expert Interviews

eLearning Expands Osteoporosis Care for Underserved Communities

In this week's news roundup from Rheumatology Network, we feature a one-on-one interview with Dr. Michael Lewiecki.

Addressing Patients' Concerns With Biosimilars

September 16, 2022

Drs Roy M. Fleischmann and Joel M. Gelfand discuss addressing patient concerns to biosimilars and provide take-home messages to clinicians utilizing biosimilars.

Clinician Confidence in Biosimilars

September 16, 2022

Roy M. Fleischmann, MD, and Joel M. Gelfand, MD, MSCE, FAAD, address the importance of clinician confidence in biosimilars.

Challenges With Biosimilars Being Approved in the US

September 16, 2022

An expert rheumatologist and a dermatologist discuss challenges to bringing biosimilars to the United States.

Treat to Target In Lupus Management

September 15, 2022

Anne E. Winkler, MD, PhD, MACP and Kristi V. Mizelle, MD, MPH, FACR hypothesize about the role and future of a treat to target approach in patients with lupus.

Treatment Goals for Patients with Lupus

September 15, 2022

Kristi V. Mizelle, MD, MPH, FACR shares her treatment goals and discusses the patient characteristics she factors when deciding on a choice of treatment for her patients.

Background to MIRROR Study in Gout

September 12, 2022

Orrin M. Troum, MD, discusses the background to the MIRROR study in gout.

Background to Gout

September 12, 2022

Orrin M. Troum, MD, and Jeff R. Peterson, MD, discuss burden, treatment landscape, and unmet needs in gout.

How to Switch Patients to Biosimilars

September 09, 2022

Expert rheumatologist and dermatologist, Drs Roy M. Fleischmann and Joel M. Gelfand, discuss the impact of switching patients to biosimilars.

Role of Biosimilars and Assessing Clinical Impact

September 09, 2022

Drs Roy M. Fleischmann and Joel M. Gelfand discuss the roles of biosimilars and how to assess efficacy once a patient is switched to a biosimilar.

Impact of Diagnosis Delay on Long Term Lupus Outcomes

September 08, 2022

Drs. Anne E. Winkler and Kristi V. Mizelle discuss the negative long term disease outcomes noted in patients who experience a delay in their lupus diagnosis.